Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML

Fig. 7

SUCLG2-AS1 regulates the expression of JAK1 through competitive binding of miR-17-5p. A The validation of JAK1 expression in AML cells and normal cells by WB. B The luciferase reporter assay validated the relationships between miR-17-5p and JAK1. C Ago2 RNA-binding protein immunoprecipitation assay to verify miR-17-5p binding with JAK1. D The regulation of SUCLG2-AS1 on the expression level of JAK1 through miR-17-5p in AML cells by qRT-PCR. E The regulation of SUCLG2-AS1 on the expression level of JAK1 through miR-17-5p in AML cells by WB

Back to article page